Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives $20.83 Consensus Price Target from Analysts

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) have earned an average rating of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $20.83.

Several brokerages have recently weighed in on CCRN. Benchmark decreased their target price on shares of Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Barrington Research decreased their target price on shares of Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating on the stock in a research report on Monday, May 6th.

Cross Country Healthcare Stock Performance

NASDAQ:CCRN opened at $16.48 on Friday. The firm’s 50-day moving average is $14.41 and its 200-day moving average is $17.27. Cross Country Healthcare has a 52-week low of $12.87 and a 52-week high of $26.74. The company has a market cap of $573.01 million, a price-to-earnings ratio of 12.68, a PEG ratio of 2.14 and a beta of 0.63.

Cross Country Healthcare (NASDAQ:CCRN) last issued its earnings results on Wednesday, May 1st. The business services provider reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.02. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. The business had revenue of $379.17 million for the quarter, compared to analyst estimates of $374.38 million. During the same period in the previous year, the business earned $0.84 EPS. The firm’s revenue was down 39.1% on a year-over-year basis. Equities analysts predict that Cross Country Healthcare will post 0.73 EPS for the current year.

Insiders Place Their Bets

In other Cross Country Healthcare news, insider Phillip Lyn Noe sold 9,646 shares of the business’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $14.19, for a total value of $136,876.74. Following the completion of the transaction, the insider now directly owns 10,162 shares of the company’s stock, valued at $144,198.78. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Cross Country Healthcare news, insider Phillip Lyn Noe sold 9,646 shares of the business’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $14.19, for a total value of $136,876.74. Following the completion of the transaction, the insider now directly owns 10,162 shares of the company’s stock, valued at $144,198.78. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Marc S. Krug sold 13,657 shares of the business’s stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $14.82, for a total transaction of $202,396.74. Following the completion of the transaction, the insider now directly owns 36,020 shares of the company’s stock, valued at $533,816.40. The disclosure for this sale can be found here. Insiders own 4.90% of the company’s stock.

Institutional Investors Weigh In On Cross Country Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. GAMMA Investing LLC bought a new stake in shares of Cross Country Healthcare during the fourth quarter worth approximately $28,000. Gladius Capital Management LP raised its stake in shares of Cross Country Healthcare by 37.1% during the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock worth $43,000 after buying an additional 515 shares during the last quarter. Denali Advisors LLC raised its stake in shares of Cross Country Healthcare by 3,885.5% during the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock worth $103,000 after buying an additional 5,362 shares during the last quarter. EMC Capital Management bought a new stake in shares of Cross Country Healthcare during the first quarter worth approximately $155,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Cross Country Healthcare during the first quarter worth approximately $195,000. 96.03% of the stock is owned by institutional investors.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.